CNS Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for CEO and President Rami Levin
I'm PortAI, I can summarize articles.
CNS Pharmaceuticals Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission, identifying Rami Levin as the beneficial owner. Levin serves as the company's CEO, President, and Director. The full filing is accessible through the SEC's EDGAR system.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments